Nevirapine
Back to searchMolecule Structure
Scientific Name
Nevirapine
Description of the Drug
Nevirapine is a non-nucleoside reverse transcriptase inhibitor used as part of a management regimen for HIV-1 virus infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00238
http://www.drugbank.ca/drugs/DB00238
Brand Name(s)
Nevirapine, Viramune, Viramune xr
Company Owner(s)
Micro Labs Ltd, Cipla Ltd, Apotex Inc, Mylan Laboratories Ltd, Sandoz Inc, Macleods Pharmaceuticals Ltd, Boehringer Ingelheim Pharmaceuticals Inc, Alvogen Inc, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3318 | |
PharmGKB | PA450616 | |
Human Metabolome Database | HMDB0014383 | |
DrugBank | DB00238 | |
PubChem: Thomson Pharma | 14872507 | |
PubChem | 4463 | |
Mcule | MCULE-8608154492 | |
NMRShiftDB | 60032853 | |
LINCS | LSM-5336 | |
Nikkaji | J420.601K | |
PDBe | NVP | |
BindingDB | 1434 | |
EPA CompTox Dashboard | DTXSID7031797 | |
DrugCentral | 1904 | |
Brenda | 1896 | |
ChemicalBook | CB9743074 | |
rxnorm | NEVIRAPINE | VIRAMUNE |
PubChem: Drugs of the Future | 12014582 | |
KEGG Ligand | C07263 | |
ChEBI | 63613 | |
ZINC | ZINC000000004778 |